Genrab Inc. has completed a private placement with aggregate gross proceeds of $5.6 million dollars.

AD2C platform provides a novel, antibody-engineering-free approach ... such as portfolio management or data aggregation. Develop and improve features of our offerings. Gear advertisements and ...

The Times Opinion columnist discusses religion and belief — at this moment in our politics and in our lives more generally.

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Prior to the site-specific biotinylation of the rat anti-HRP ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Express™ Antibody Expression service. This new offering enables biotechnology ...

Glomerulonephritis can affect the normal functioning of the kidneys, with consequences ranging from subtle, easily dismissed ...

A new fiber-optic device enables rapid, microscope-free detection of biomarkers using a gliding motility assay. The platform ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...